Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S. provides expert guidance and practical know-how for lawyers working in this burgeoning area of the law. This is your opportunity to meet the authors who contributed to this comprehensive guide and go-to reference for all things biosimilars.
Q&A with March’s Featured Author: Beth Ashbridge
Beth Ashbridge is an Associate in Goodwin’s New York office.
What made you want to contribute to the Guide?
From day one, working on the BMW team has been a fun and collaborative experience. The Guide was an extension of that feeling of pride and teamwork that I have come to expect from working with this group of experts.
What do you hope people learn from the Guide?
The Guide is an excellent go-to resource for anyone practicing in the Biosimilars space. It can be used as both a quick reference resource and a deeper dive text, which makes it an invaluable document for anyone with an interest in the field.
What did you learn from working on the Guide?
I learned about the bigger picture issues framing Biosimilars litigation. The Guide provides detail, but it also puts the whole process into context for the reader.
Feel free to contact the authors should you have questions or wish to discuss any topics covered in the Guide or on Big Molecule Watch.
Beth Ashbridge: bashbridge@goodwinlaw.com